Gene vaccine for anti SARS coronal virus and use thereof

A coronavirus and gene vaccine technology, applied in antiviral agents, applications, gene therapy, etc., can solve the problems of poor antigenicity, instability, and increased production costs of vaccines, and achieve the effects of convenient transportation, cheap price, and easy preparation
CN1449826AInactive Publication Date: 2003-10-22WUHAN UNIV

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
WUHAN UNIV
Publication Date
2003-10-22
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention discloses a gene vaccine for resisting SARS coronavirus and its application, including eucaryotic expressino plasmid containing total or partial gene fragment of total-length gene sequence of SARS coronavirus S protein. The nucleotide sequence of coded SARS coronavirus S protein can be operatively connected with a promotor, then it can express the complete or partial polypeptide of the coded SARS coronavirus S protein in vivo. The described gene vaccine can be used for immunizing host including human body and rodent, for example mouse to make it produce specific protective body fluid immune and cell immune to resist the infection of SARS coronavirus. Said invention is good in stability, convenient in production and low in cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The present invention relates to the field of vaccines for the prevention and treatment of atypical pneumonia caused by SARS coronavirus, in particular to vaccines encoding the nucleic acid sequence of the SARS coronavirus S protein. It also relates to the use of the vaccine in anti-SARS coronavirus. Background technique

[0002] Severe Acute Respiratory Sydrome (SARS) called atypical pneumonia has occurred in more than 20 countries and regions around the world. According to statistics from the World Health Organization, as of 17:00 Geneva time on May 22, the source has reported a total of 8,046 cases and 682 deaths worldwide; a total of 5,285 SARS cases and 303 deaths have been reported in the mainland. This sudden disaster has brought huge personal and economic losses to people all over the world, especially the Chinese people.

[0003] As of May 22, there are only chemical drugs that can improve symptoms, such as "sivelestat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More